Want to join the conversation?
$HQY lifted its 2017 revenue outlook to $173-177MM from previous forecast of $170-174MM and its non-GAAP EPS guidance to range of $0.47-0.49 from prior estimate of $0.45-0.47. The company also raised its 2017 adjusted EBITDA outlook to $58-60MM from $56-58MM. $HQY sees stock-based compensation expense of $5-6MM and effective tax rate of about 36%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.